Moffitt Cancer Center Recognized as Tampa Bay Times Top Workplace for 11th Time

SpaceX to Take Moffitt Investigators’ Experiment to the International Space Station

Their company, Cadw Therapeutics, is partnering with SpacePharma to study stress and DNA damage caused by space travel in hopes of developing...

Moffitt Gets Boost in State Funding to Support Pasco County Project

The new Florida budget awaiting the governor’s signature includes nearly $150 million allocated for the cancer center

Evan Zaslow Joins Moffitt Cancer Center as New Vice President of Payer Strategies

COVID Infection Rates in Hillsborough County May Have Been Higher Than Reported at Height of Pandemic

Moffitt study shows COVID prevalence between October 2020 and March 2021 was twofold higher

Moffitt Researchers Perform Comprehensive Analysis of Cellular and Molecular Characteristics of Acral Melanoma

Differences identified between acral and non-acral melanoma may lead to potential therapeutic targets

Moffitt Study Finds Cancer Patients Do Benefit From COVID-19 Vaccination

The rate of developing antibodies varies by cancer type and treatment

Moffitt Researchers Develop First Patient Derived Cells to Study Leptomeningeal Disease

The cells provide a new opportunity to study pathology and potential therapeutics

Moffitt Researchers Identify Key Genomic Alterations and Potential Therapeutic Vulnerabilities in Transformed Cutaneous TCell Lymphoma

The discoveries from this multiomics study could drive new therapies for this rare cancer

Specific Cancer Driving Protein Plays Important Role in Lung Cancer Development, Moffitt Researchers Say

ΔNp63 controls enhancer regions of genes involved in the regulation of cell identity

Marcia Cross Joins Moffitt’s National Board of Advisors

Acclaimed actress is co-founder of the HPV Cancers Alliance

Moffitt Researchers Analyze VA Data to Study Prostate Cancer Disparities

“Equal access system” shows how African American men are disproportionately affected

Moffitt Researchers Unlock Immune Cell Contributions that Could Lead to New Therapies for Endometrial Cancer

IgA interactions with pIgR govern anti-tumor activity and are associated with improved outcomes

Moffitt Researchers Discover Mechanism Controlling Tertiary Lymphoid Structure Formation in Tumors

Finding could potentially enhance response to immunotherapy for tumors that can’t be removed

Moffitt Names Dr. Elsa R. Flores Associate Center Director of Basic Science

Flores will oversee the Basic Science Division, which includes the Cancer Physiology, Drug Discovery, Immunology, Molecular Oncology and Tumor...

News Releases